DUBLIN--(BUSINESS WIRE)--The "Narcolepsy - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Narcolepsy - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Narcolepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 4, 4, 4, 5, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.
Narcolepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Introduction
- Report Coverage
- Narcolepsy - Overview
- Narcolepsy - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Narcolepsy - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Narcolepsy - Companies Involved in Therapeutics Development
- Avadel Pharmaceuticals Plc
- Bioprojet SCR
- Evotec AG
- F. Hoffmann-La Roche Ltd
- H.A.C. Pharma
- Heptares Therapeutics Ltd
- Jazz Pharmaceuticals Plc
- Ono Pharmaceutical Co Ltd
- OptiNose US Inc
- SK Biopharmaceuticals Co Ltd
- Taisho Pharmaceutical Holdings Co Ltd
- Takeda Pharmaceutical Co Ltd
- Theranexus SAS
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vtngnk/narcolepsy?w=4
